| __timestamp | BioMarin Pharmaceutical Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 129764000 | 9216000000 |
| Thursday, January 1, 2015 | 152008000 | 8296000000 |
| Friday, January 1, 2016 | 209620000 | 10044000000 |
| Sunday, January 1, 2017 | 241786000 | 11560000000 |
| Monday, January 1, 2018 | 315264000 | 10558000000 |
| Tuesday, January 1, 2019 | 359466000 | 9351000000 |
| Wednesday, January 1, 2020 | 524272000 | 8933000000 |
| Friday, January 1, 2021 | 470515000 | 8284000000 |
| Saturday, January 1, 2022 | 483669000 | 7952000000 |
| Sunday, January 1, 2023 | 577065000 | 8200000000 |
| Monday, January 1, 2024 | 580235000 | 8480000000 |
Cracking the code
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. This analysis compares the cost of revenue for Teva Pharmaceutical Industries Limited and BioMarin Pharmaceutical Inc. from 2014 to 2023. Over this period, Teva's cost of revenue consistently dwarfed BioMarin's, averaging around 9.2 billion annually, compared to BioMarin's 346 million. However, BioMarin's cost of revenue grew by approximately 345% from 2014 to 2023, while Teva's saw a decline of about 11% in the same period. This shift highlights BioMarin's aggressive expansion and Teva's strategic cost management. The data reveals a fascinating narrative of growth and adaptation, offering insights into the financial strategies of these pharmaceutical powerhouses. As the industry faces new challenges, these trends provide a glimpse into the future of pharmaceutical economics.
Analyzing Cost of Revenue: Sanofi and BioMarin Pharmaceutical Inc.
Cost of Revenue Trends: Zoetis Inc. vs Teva Pharmaceutical Industries Limited
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Corcept Therapeutics Incorporated
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Cytokinetics, Incorporated
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Alkermes plc's Expenses
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. vs Exelixis, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Telix Pharmaceuticals Limited
Cost Insights: Breaking Down BioMarin Pharmaceutical Inc. and Xenon Pharmaceuticals Inc.'s Expenses
BioMarin Pharmaceutical Inc. vs ACADIA Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Viridian Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: BioMarin Pharmaceutical Inc. vs MiMedx Group, Inc.